NO922169L - ANTISENS Oligonucleotide Inhibition of Papillomavirus - Google Patents
ANTISENS Oligonucleotide Inhibition of PapillomavirusInfo
- Publication number
- NO922169L NO922169L NO92922169A NO922169A NO922169L NO 922169 L NO922169 L NO 922169L NO 92922169 A NO92922169 A NO 92922169A NO 922169 A NO922169 A NO 922169A NO 922169 L NO922169 L NO 922169L
- Authority
- NO
- Norway
- Prior art keywords
- oligonucleotide
- oligonucleotides
- papillomavirus
- papilloma
- messenger
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 10
- 241001631646 Papillomaviridae Species 0.000 title abstract 3
- 230000005764 inhibitory process Effects 0.000 title 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 3
- 230000000692 anti-sense effect Effects 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 1
- 206010013710 Drug interaction Diseases 0.000 abstract 1
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000003154 papilloma Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oligonukleotider og ollgonukleotidanaloger er tllvele- brakt og har evne for antlsenslnterakBjon med messenger-RKA fra paplllomavirus. Slike oligo- nukleotlder eller oligonukleotidanaloger kan bli anvendt for diagnostikk og terapeutiske midler samt for forskning. I henhold til foretrukne utførelsesformer er ollgonukleotld eller ollgonukleotidanaloger tllvele- brakt og disse er hybridlserbare med et messenger-RNA fra et paplllomavirus. Oligonukleotldet eller oligo- nukleotldanalogen kan også inhlbere funksjonen av RNA og er derfor nyttig for terapi for Infeksjoner med silke paplllomavirus. Deler av papillomavlruset blir målsøkt for antisensangrep. Ollgonukleotidene kan derfor fortrinnsvis hybridlsere med E2-, El-, E7- eller E6-7-messenger RNA.Oligonucleotides and oligonucleotide analogs are abundant and have the capability for antisense drug interaction with messenger RKA from papilloma virus. Such oligonucleotides or oligonucleotide analogs can be used for diagnostics and therapeutics as well as for research. According to preferred embodiments, oligonucleotide or oligonucleotide analogs are provided and these are hybridizable with a messenger RNA from a papilloma virus. The oligonucleotide or oligonucleotide analog may also inhibit the function of RNA and is therefore useful for therapy for Silk papillomavirus infections. Parts of the papilloma breeding virus are targeted for antisense attacks. The oligonucleotides can therefore preferably hybridize with E2, E1, E7 or E6-7 messenger RNA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45519689A | 1989-12-04 | 1989-12-04 | |
| PCT/US1990/007067 WO1991008313A1 (en) | 1989-12-04 | 1990-12-03 | Antisense oligonucleotide inhibition of papillomavirus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO922169D0 NO922169D0 (en) | 1992-06-01 |
| NO922169L true NO922169L (en) | 1992-07-27 |
Family
ID=26781834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92922169A NO922169L (en) | 1989-12-04 | 1992-06-01 | ANTISENS Oligonucleotide Inhibition of Papillomavirus |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO922169L (en) |
-
1992
- 1992-06-01 NO NO92922169A patent/NO922169L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO922169D0 (en) | 1992-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943198L (en) | Papillomavirus antisense oligonucleotide inhibition | |
| Krol et al. | Primary and secondary structures of chicken, rat and man nuclear U4 RNAs. Homologies with U1 and U5 RNAs | |
| FI922593A0 (en) | INHIBITION OF PAPILLOMAVIRUS MED ÇANTISENSEÇ-OLIGONUCLEOTIDER. | |
| ES2105698T3 (en) | OLIGONUCLEOTIDES MODIFIED WITH 7-DEAZAPURINE. | |
| DE69330372D1 (en) | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH HEPATITIS C VIRUSES | |
| ATE322493T1 (en) | CYCLOHEXENE NUCLEIC ACIDS | |
| DE69829115D1 (en) | COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C VIRUS-RELATED DISEASES | |
| ATE373671T1 (en) | AMINOOXY-MODIFIED OLIGONUCLEOTIDES | |
| KR930701466A (en) | Inhibition of type A influenza virus, ANA ARBOR STRAIN H2N2 by antisense oligonucleotides | |
| DK0517796T3 (en) | Oligonucleotide analogues | |
| EP1443051A3 (en) | Sugar modified oligonucleotides that detect and modulate gene expression | |
| ES2181765T3 (en) | DETECTION OF HUMAN VIRUS PAPILOMA IN A NUCLEIC ACID AMPLIFICATION PROCESS USING GENERAL PRIMERS. | |
| WO2006047842A3 (en) | Modified nucleosides for rna interference | |
| Tamm | Definition of subclasses of nucleoplasmic RNA | |
| AU2006300864A1 (en) | Human microrna targets in HIV genome and a method of identification thereof | |
| Smith et al. | Oligo (A) not coded by DNA generating 3'-terminal heterogeneity in a lambda phage RNA. | |
| NO922169L (en) | ANTISENS Oligonucleotide Inhibition of Papillomavirus | |
| NO965017D0 (en) | Oligonucleotides with anti-cytomegalovirus activity | |
| WO2001040478A3 (en) | Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof | |
| Pogo et al. | Biogenesis of poxviruses: inactivation of host DNA polymerase by a component of the invading inoculum particle | |
| Sharma et al. | Constitutive heterochromatin and karyotype variation in Indian pygmy mouse, Mus dunni | |
| Hossain et al. | Homo-N-nucleosides: Incorporation into oligonucleotides and antiviral activity | |
| Kumar et al. | Characterization and physical mapping of 18S and 5S ribosomal genes in Indian major carps (Pisces, Cyprinidae) | |
| CN100368423C (en) | Small interference RNA molecule (SiRNA) capable of effectively killing and wounding tumour cell pointed at PLK1 mRNA, its mixture and use | |
| ES2048652A1 (en) | Methods for amplification of genome and mixtures of initiator oligonucleotides for the detection and identification of related genomic sequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |